midazolam has been researched along with tofisopam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hovi-Viander, M; Kanto, J; Scheinin, H; Scheinin, M | 1 |
| Cseh, A; Drabant, S; Klebovich, I; Szentpéteri, I; Tóth, M; Varga, B; Végso, G | 1 |
2 trial(s) available for midazolam and tofisopam
| Article | Year |
|---|---|
Tofisopam and midazolam: differences in clinical effects and in changes of CSF monoamine metabolites.
Topics: Aged; Anti-Anxiety Agents; Benzodiazepines; Biogenic Amines; Blood Pressure; Double-Blind Method; Heart Rate; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hypnotics and Sedatives; Methoxyhydroxyphenylglycol; Midazolam; Middle Aged; Sleep | 1985 |
Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam.
Topics: Adjuvants, Anesthesia; Antidepressive Agents; Area Under Curve; Benzodiazepines; Cytochrome P-450 CYP3A; Drug Interactions; Half-Life; Humans; Intestinal Mucosa; Intestines; Liver; Male; Midazolam | 2008 |